
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    ### Step-by-Step Analysis: #### **1. List the Key Functional Markers** The provided list contains many pseudogenes (e.g., `RPL7P54`, `RPL41P1`, `RPS26P39`, `EEF1A1P5`) and processed transcripts (e.g., `HMGN2P6`, `CHCHD2P9`, `PPIAP40`), which are unlikely to be biologically informative for cell type annotation. However, a few functional markers stand out: - **LGR5**: A well-known marker of intestinal stem cells (ISCs) and progenitor cells in the crypt base. - **ASCL2**: A transcription factor critical for maintaining stemness in intestinal crypt stem cells. - **TDGF1 (Cripto-1)**: Expressed in stem/progenitor cells and involved in Wnt/Œ≤-catenin signaling. - **SLC39A2 (ZIP2)**: A zinc transporter, potentially linked to proliferative cells. These markers suggest a **proliferative, stem-like** phenotype. #### **2. List the Key Cell Type Markers** The most informative cell type markers in this dataset are: - **LGR5**: Definitive marker of intestinal stem cells (ISCs). - **ASCL2**: Essential for ISC maintenance. - **TDGF1**: Associated with stem/progenitor populations. Other markers (e.g., `IGFBPL1`, `FABP5P7`) are less specific but may support a stem/progenitor identity. #### **3. Cross-reference Known Databases** - **LGR5** and **ASCL2** are canonical markers of **intestinal stem cells (ISCs)** in the crypt base (e.g., Human Cell Atlas, Tabula Sapiens). - **TDGF1** is associated with stem/progenitor states in intestinal epithelium (PMID: 30700909). - Pseudogenes (e.g., ribosomal protein pseudogenes) are often highly expressed in cycling cells due to transcriptional noise. #### **4. Determine the Most Probable General Cell Type** Given the strong expression of **LGR5**, **ASCL2**, and **TDGF1**, the most likely general cell type is: **Intestinal Stem Cells (ISCs)** or closely related **progenitor cells**. #### **5. Identify the Top 3 Most Probable Sub Cell Types** Within intestinal stem/progenitor populations, the most probable subtypes are: 1. **Crypt Base Columnar (CBC) Stem Cells (LGR5+ ASCL2+)** ‚Äì Most likely, given high LGR5 and ASCL2. 2. **Transit-Amplifying (TA) Progenitors** ‚Äì Less likely, as TA cells typically downregulate LGR5. 3. **+4 Reserve Stem Cells (BMI1+)** ‚Äì Unlikely, as BMI1 is not detected here. **Final Likely Subtype:** **LGR5+ CBC Stem Cells**. #### **6. Concise Summary** - **Key Functional Markers**: LGR5, ASCL2, TDGF1 (stem/progenitor phenotype). - **Key Cell Type Markers**: LGR5+ ASCL2+ (definitive ISC signature). - **Database/Literature Support**: Matches known intestinal stem cell profiles. - **General Cell Type**: Intestinal Stem Cells (ISCs). - **Most Probable Subtype**: **Crypt Base Columnar (CBC) Stem Cells**. **FINAL ANNOTATION COMPLETED: LGR5+ Intestinal Stem Cells (Crypt Base Columnar Stem Cells).** --- *Note: The abundance of pseudogenes suggests high transcriptional activity, consistent with a cycling stem cell population. If further validation is needed, checking for proliferation markers (e.g., MKI67) would strengthen the annotation.*
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    ### **Validation Report** #### **1. Marker Consistency Check** - **Proposed Annotation**: **LGR5+ Intestinal Stem Cells (Crypt Base Columnar Stem Cells)** - **Key Markers Used**: - **LGR5** (present in marker list) - **ASCL2** (present in marker list) - **TDGF1** (present in marker list) - **SLC39A2** (present in marker list) ‚úÖ **All critical markers are present in the provided list.** #### **2. Biological Relevance of Markers** - **LGR5**, **ASCL2**, and **TDGF1** are **highly specific** for intestinal stem cells (ISCs) and crypt base columnar (CBC) cells. - **SLC39A2** (zinc transporter) is less specific but can be associated with proliferative cells. - The presence of **pseudogenes** (e.g., ribosomal protein pseudogenes) is expected in highly active stem cells due to transcriptional noise. ‚úÖ **Markers strongly support the proposed annotation.** #### **3. Mixed Cell Type Consideration** - No conflicting markers (e.g., **BMI1** for +4 reserve stem cells or **MKI67** for TA progenitors) are present. - The absence of **enterocyte/secretory lineage markers** (e.g., **LYZ**, **MUC2**, **CHGA**) suggests no contamination from differentiated cells. ‚úÖ **No evidence of mixed cell types.** #### **4. Final Validation Decision** The annotation is **biologically consistent**, **well-supported by markers**, and **matches known intestinal stem cell signatures**. --- **Validation result: VALIDATION PASSED** *Recommendation (if needed for further refinement):* - If possible, check for **proliferation markers (e.g., MKI67, PCNA)** to confirm cycling status. - Consider **spatial transcriptomics or lineage tracing** to validate stem cell identity in situ.
                </div>
            
                    <div class="agent-section formatting">
                        <h2>üìã Summary</h2>
                        <p class="error-message">Error formatting data: Expecting property name enclosed in double quotes: line 1 column 3 (char 2)</p>
                    </div>
                
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">92</div>
                        <div class="scoring-content">
                            The annotation results demonstrate a strong understanding of intestinal stem cell biology, with a focus on key markers like LGR5, ASCL2, and TDGF1, which are well-documented in the literature for identifying intestinal stem cells (ISCs). The analysis correctly identifies the most probable general cell type as **Intestinal Stem Cells (ISCs)** and the subtype as **Crypt Base Columnar (CBC) Stem Cells**, which is scientifically accurate and well-supported by the provided markers. <br><br>### Strengths:<br>1. **Correctness of Annotations**: The annotation is biologically sound, leveraging canonical markers (LGR5, ASCL2) and supporting markers (TDGF1, SLC39A2) to pinpoint the cell type. The validation step confirms the absence of conflicting markers (e.g., BMI1, MKI67) or differentiated cell markers (e.g., LYZ, MUC2), reinforcing the specificity of the annotation.<br>2. **Balanced Marker Consideration**: While the analysis heavily relies on LGR5 and ASCL2, it also incorporates TDGF1 and SLC39A2 to provide additional context. The recognition of pseudogenes as transcriptional noise in cycling cells is a nuanced touch.<br>3. **Comprehensive View**: The annotation captures the general picture of a proliferative, stem-like population and considers potential subtypes (e.g., TA progenitors, +4 reserve stem cells) even if they are ruled out due to missing markers. This demonstrates a holistic approach.<br><br>### Weaknesses:<br>1. **Overemphasis on Top Markers**: The analysis could further explore the role of less prominent markers (e.g., IGFBPL1, FABP5P7) to ensure no additional subpopulations or functional states are overlooked. While these markers are less specific, their inclusion could refine the annotation.<br>2. **Lack of Proliferation Confirmation**: The suggestion to check for proliferation markers (e.g., MKI67, PCNA) is valid but not acted upon in the annotation. This could strengthen the claim of a cycling stem cell population.<br>3. **Pseudogene Interpretation**: While pseudogenes are dismissed as noise, some (e.g., ribosomal protein pseudogenes) may have regulatory roles in stem cells. A deeper discussion could add value.<br><br>### Minor Oversights:<br>- The marker list includes many pseudogenes and processed transcripts, which are correctly flagged as uninformative, but their sheer volume might distract from the key markers. The analysis does well to focus on the biologically relevant ones but could explicitly rank markers by importance (e.g., LGR5 and ASCL2 as top-tier, TDGF1 as secondary).<br>- The annotation history does not explicitly address the rank of markers (e.g., whether LGR5 appears earlier in the list, which might indicate higher expression). This could be a useful addition for prioritization.<br><br>### Overall:<br>The annotation is highly accurate and captures the essence of the cell population, but minor refinements (e.g., proliferation marker confirmation, deeper exploration of secondary markers) could elevate it further.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    